News

The most effective treatments for eczema accomplish three things: They calm inflammation, bring relief from itch and restore ...
First FDA-approved medication for atopic dermatitis (eczema), plaque psoriasis, and seborrheic dermatitis to win prominent “Breakthrough ...
Data from the late-stage trial of amlitelimab weren’t as strong as the results seen in Phase 2, adding to doubts about a drug ...
Apollo Therapeutics’ $15 million bet on Avalo’s anti-IL-18 monoclonal antibody appears to have paid off after the candidate ...
If you or someone you love has eczema, you know treating it can be frustrating. It takes a lot of trial and error to f ...
Sanofi (NASDAQ:SNY) stock took a beating Thursday after its latest eczema drug trial left Wall Street unconvinced, even ...
World Atopic Eczema Day 2025 highlights the lifelong impact of atopic eczema, a common inflammatory skin disease that often ...
Sanofi (SNY) stock drops after Phase 3 trial results for amlitelimab, its experimental therapy for eczema, disappointed ...
Hand eczema, or hand dermatitis, is an inflammatory skin condition. Swollen, itchy, scaly, discolored rashes form on the fingers and hands. The skin may blister and crack, and it can be painful. Hand ...
World Atopic Eczema Day 2025 calls for early intervention, better care and greater awareness of the hidden toll of atopic ...
Doctors have shared their top tips for travelling with eczema, offering some wise words for people who find heading to ...
Shares in French drugmaker Sanofi fell more than 10% on Thursday, wiping nearly $13 billion off its market value, after ...